Navigating the IPR maze
The Indian Patent Office’s decision to grant the patent for Gilead’s Hepatitis C treatment drug, Sovaldi, has attracted much criticism. This change of heart — given the rejection of the same patent application in …
Read MoreTag: TRIPS